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Adenoma Characteristics at First Colonoscopy as Predictors
of Adenoma Recurrence and Characteristics at Follow-up
ROSALIND U. VAN STOLK,* GERALD J. BECK,‡ JOHN A. BARON,§ ROBERT HAILE,\
and ROBERT SUMMERS¶ for the POLYP PREVENTION STUDY GROUP
Departments of *Gastroenterology and ‡Biostatistics and Epidemiology, Cleveland Clinic Foundation, Cleveland, Ohio; §Section of Biostatistics
and Epidemiology, Dartmouth Medical School, Hanover, New Hampshire; \Department of Preventive Medicine, University of Southern
California/Norris Comprehensive Cancer Center, Los Angeles, California; and ¶Department of Internal Medicine, University of Iowa Hospitals
and Clinics, Iowa City, Iowa

Background & Aims: All patients with colorectal adenomas may not require identical follow-up. We aimed to
determine if adenoma characteristics at initial colonoscopy could predict adenoma recurrence or characteristics at follow-up. Methods: The number of adenomas
and the size, type, and degree of atypia in 479 patients
in a polyp prevention trial were evaluated as predictors
of the same characteristics at follow-up using odds
ratios (ORs) with 95% confidence intervals (CIs). Multiple logistic regression analysis was performed to
determine if several baseline characteristics were simultaneously associated with outcome. Results: Although
several characteristics were significant predictors of
recurrence univariately, by multivariate analysis, multiple adenomas at follow-up were more likely when
patients had $3 baseline adenomas (OR, 2.25; 95%
CI, 1.20–4.21) or at least 1 tubulovillous adenoma
(OR, 2.12; 95% CI, 1.12–4.02). No specific characteristic was associated with recurrence of high-risk polyps
(H1 cm, villous, severe atypia). Seventy percent of
patients with 1 or 2 baseline adenomas had no recurrence, and only 3.3% had any adenomas of clinical
concern. Conclusions: Number and type of baseline
adenomas predict recurrent adenomas, but the recurrence is rarely of clinical concern. Patients with 1 or 2
tubular adenomas constitute a low-risk group for whom
follow-up might be extended beyond 3 years.

olorectal adenomas are common benign neoplastic
lesions found in up to 40% of Americans older than
50 in colonoscopy studies.1–3 Age, site, and population
characteristics are similar in patients with large bowel
adenomas and those with colorectal cancer.4–6 These older
epidemiological data underlie the universal acceptance of
the adenoma-carcinoma hypothesis. Until recently, all
patients found to have adenomas were assumed to be at
substantial risk of developing colorectal cancer and thus
were believed to benefit from lifelong aggressive polyp
surveillance.5,7–9 However, most adenomas never become
cancerous,10 and recent reports have suggested that there

C

are both low- and high-risk populations among patients
with large bowel adenomas.11–13
Larger size, increased atypia, and villous histology
increase the likelihood that a specific polyp may have
cancer already within it14–16 or will develop cancer over
time.17,18 Patients with multiple adenomas or adenomas
with advanced pathological features have been found to
have an increased risk of developing colon cancer.11,15,19
However, these studies were conducted before systematic
excision of all polyps was common during colonoscopy
and thus may overestimate the risk of cancer developing
after removal of colorectal adenomas.
We used data from a chemoprevention trial of adenoma
recurrence to clarify whether baseline adenoma characteristics could be helpful in assessing either the risk of
adenoma recurrence or the features of recurrent adenomas. Specifically, we wished to address whether baseline
adenoma characteristics were predictive of the number of
adenomas or the features of adenomas that were subsequently detected.

Materials and Methods
The Polyp Prevention Study was a randomized, doubleblind, placebo-controlled clinical trial of antioxidant vitamins
(b-carotene and vitamins C and E) to prevent recurrent
colorectal adenomas.20 The study involved six clinical centers
in the United States. Patients were eligible if they had a large
bowel adenoma removed during the previous 3 months,
underwent a complete colonoscopy and were judged free of
polyps, were younger than 80 years, and were in good health.
The study design included a baseline colonoscopy to identify
patients with adenomas, a 1-year clearing examination, and a final
study examination 3 years later (year 4). The primary study end
point was the occurrence of new adenomas between the colonoscopic
examinations at year 1 and year 4. Of 864 patients randomized,

Abbreviations used in this paper: CI, confidence interval; OR, odds
ratio.
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751 patients had both follow-up examinations and provided
data for the primary efficacy analysis.
Because the antioxidant vitamins studied had no effect on
polyp recurrence or characteristics,20 we evaluated the adenoma
data from all subjects rather than only those who received
placebo. Of the 751 patients completing the parent trial, 541
were patients for whom the initial colonoscopy was their first
colonoscopy ever, defined as the baseline examination. Complete histological data were available in 479 of these patients
(77% male; mean age, 60 years; age range, 25–78). This
comprised the final group used for analysis. It should be noted
that the 62 patients excluded for incomplete histology did not
differ from the final study group with respect to age, gender,
race, and number or type of adenomas.
At baseline colonoscopy, we identified the number of
adenomas and the size, histological type, and degree of atypia of
the most advanced adenoma in each patient. The designation
most advanced was determined ranking atypia from most
severe to least, then type, and finally size. For the majority of
our patients (96%), the most advanced adenoma was also the
largest. The characteristics of adenomas at baseline and follow-up are given in Table 1. The adenoma characteristics from
the baseline colonoscopy were then compared with those found
at the final (year 4) colonoscopy. This is the analysis reported in
our paper.
The original study design included a 1-year clearance
examination that was standard practice at the time of patient
recruitment and was based on the concern of polyps missed at
the initial examination. The National Polyp Study addressed
the 1-year examination specifically and determined that intervention at a 1-year time point did not alter the findings of
important adenomas at a 3-year follow-up examination. Our
study reports on adenoma characteristics at a first colonoscopy
as predictors of recurrence and characteristics at a follow-up
examination 3 years after clearance (at year 4). Adenomas found

Table 1. Characteristics of Polyps at Baseline and Follow-up
Characteristics

Baseline

Follow-up

No. of adenomas
None
1
2
$3
Maximum size (cm)
,0.5
0.5–1
1–2
.2
Histological type of worst adenoma
Tubular
Tubulovillous
Villous
Atypia
Mild/moderate
Severe
Invasive cancer

n 5 479
—
64%
19%
17%
n 5 479
25%
29%
35%
11%
n 5 479
54%
46%
1 Patient
n 5 479
95%
4%
1%

n 5 479
65%
21%
8%
6%
n 5 166a
58%
32%
9%
1%
n 5 166a
82%
17%
1 Patient
n 5 166a
100%
—
—

aThree

hundred thirteen patients had no adenomas at follow-up.

at the year 4 examination were assumed to be recurrent. To test
our assumption that the findings at year 1 would not alter our
results, we repeated our analysis (results not shown) adding the
polyp data from year 1 to the baseline data. We also repeated
the analysis adding the polyp data from year 1 to the year 4
findings. Our results were not altered and are not reported here.
The mean (SD) interval between the baseline and year 4
colonoscopy was 4.2 (0.3) years.

Statistical Analysis
The association of baseline adenoma characteristics to
adenoma characteristics at the year 4 follow-up examination
was assessed using odds ratios (ORs) and their confidence
intervals (CIs). Multiple logistic regression analysis was used to
determine whether several baseline polyp characteristics were
simultaneously associated (significance level of #0.05) with
outcome at the follow-up examination. The importance of each
predictor was summarized by its OR and 95% CI. A CI that
does not include 1.0 indicates that there is a significant
relationship of the predictor with the outcome at the 5%
significance level. Age, gender, clinical center, and the time
interval between the baseline and year 4 colonoscopies were
also included in the logistic model to adjust for the effect of
these factors.

Comparison Groups
Number of adenomas. The number of baseline adenomas was analyzed as predictors in several ways. We first
evaluated recurrence risk in patients with 1 adenoma vs. 2 or
more adenomas at baseline. We then repeated the analysis
using 1 or 2 adenomas vs. 3 or more adenomas at baseline. We
chose 1 or 2 adenomas vs. 3 or more to perform most of the
analyses because evidence from several studies suggests that
patients with 1 or 2 adenomas have a similar and lower risk of
adenoma recurrence and subsequent cancer than patients with
more than 2 adenomas.11,12,19,21
Adenoma number as an outcome was also grouped in various
categories (e.g., zero vs. any adenomas, or zero and 1 vs. 2 or
more adenomas) to determine if specific baseline polyp characteristics predicted recurrence of multiple adenomas or only any
adenoma recurrence. We report both, but our main analysis
addresses the finding of multiple adenomas because patients
with recurrence of multiple adenomas represent those at higher
risk of continuing adenoma formation and cancer.11,12,22
Size of the most advanced adenoma. The size of the
most advanced adenoma at baseline was combined into two
groups: those with adenomas ,1 cm and those with adenomas
$1 cm. Adenomas found at follow-up were smaller than at
baseline, and so the size of the recurrent adenomas was
considered in two groups: ,0.5 cm vs. polyps $0.5 cm. To
accurately predict the occurrence of adenomas $0.5 cm at
follow-up out of all 479 baseline patients, patients with no
follow-up adenomas were counted in the smaller polyp size
group. We considered using a cut-point of 1 cm as an outcome;
however, the numbers were too small (17) to allow meaningful
analysis.
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Type of the most advanced adenoma. For both baseline and outcome, only the relationship of tubular adenomas vs.
tubulovillous adenomas was examined because there was only 1
patient each with a villous adenoma at baseline and at year 4,
respectively.
Atypia of the most advanced adenoma. Atypia as a
baseline feature was combined into two groups: mild or
moderate atypia vs. severe atypia combined with any malignant
polyps (adenomas containing invasive cancer). Prediction of
atypia as an outcome was not feasible because there were no
polyps with severe atypia at year 4.

Results
Predictors of Multiple Adenomas
When each baseline characteristic was considered
individually, the number of adenomas was the strongest
predictor of any adenoma recurrence at a year 4 colonoscopy or of the recurrence of multiple adenomas. This was
true when the analysis was performed using 1 vs. 2 or
more adenomas and when the analysis was performed
using 1 or 2 vs. 3 or more adenomas as the risk factor
(Figure 1). Persons with 3 or more adenomas at baseline
had more than three times the risk of having 2 or more
adenomas after year 1 compared with those with only 1 or
2 baseline adenomas (Table 2). Indeed, patients with only
1 or 2 adenomas at baseline had an almost 90% chance
(352 of 395) of having 1 or fewer adenomas at follow-up
and a 70% chance (275 of 395) of having none.
The presence of tubulovillous type and severe or
greater atypia also were significantly associated univariately with patients who later had 2 or more adenomas
(Table 2). Polyp size at baseline was not associated with a
higher rate of adenoma recurrence at year 4.
In multivariate analysis with all baseline predictors
considered simultaneously and adjusted for age, gender,
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Table 2. Relationship of Baseline Characteristics to Having
Two or More Adenomas at Follow-up
Baseline
adenoma
characteristic
Number (n 5 479)
1 or 2 (395)
$3 (84)
Size (n 5 479)
,1 cm (259)
$1 cm (220)
Type (n 5 477)
Tubular (257)
Tubulovillous
(220)
Atypia (n 5 479)
Mild/moderate
(453)
Severe/carcinoma in situ
or any invasion (26)

% With $2
adenomas

Multivariatea
OR (95% CI)

Univariate
OR (95% CI)

10.9
28.6

1.0
1.0
3.27 (1.85–5.79) 2.25 (1.20–4.21)b

12.0
16.4

1.0
1.0
1.44 (0.86–2.42) 0.86 (0.46–1.59)

9.3

1.0

1.0

19.5

2.36 (1.38–4.03) 2.12 (1.12–4.02)b

13.0

1.0

30.8

2.97 (1.24–7.13) 2.41 (0.90–6.47)

1.0

aIncludes

baseline characteristics shown as well as age, gender,
clinical center, and time interval between the baseline and year 4
colonoscopies.
bA CI that does not include 1.0 implies there is a significant relationship of
the factor with the outcome at the 5% significance level.

clinical center, and the time interval between the two
colonoscopies, having 3 or more adenomas or a tubulovillous adenoma at baseline both independently increased
the risk of having 2 or more adenomas at follow-up
(Table 2).
Predictors of Adenoma Size
A greater number of baseline adenomas also was
associated with having subsequent adenomas .0.5 cm
when each predictor was considered individually (Table
3). In addition, tubulovillous type was significantly
associated with the size of recurrent adenomas. Baseline
size seemed to be a marginally important predictor of
later polyp size but did not reach statistical significance.
When all baseline predictors were considered together,
only having 3 or more adenomas at baseline was significantly related to having a polyp of $0.5 cm.
Predictors of Histological Type

Figure 1. Percent of patients with any adenoma (——) or two or more
adenomas (----) at year 4 colonoscopy depending on the number of
baseline adenomas. 95% CIs are shown by the vertical bars.

When predicting the likelihood of having a
tubulovillous adenoma at follow-up, baseline size and the
presence of severe or worse atypia individually were
important (Table 4). The number of adenomas and the
type were not significantly associated with recurrent
adenomas of tubulovillous type. By multivariate analysis,
no factor was significantly related to having a tubulovillous adenoma after baseline. However, size and atypia
were marginally important (Table 4).
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Table 3. Relationship of Baseline Characteristics to Having
at Least One Adenoma of . 0.5 cm at Follow-up
Baseline
adenoma
characteristic
Number (n 5 479)
1 or 2 (395)
$3 (84)
Size (n 5 479)
,1 cm (259)
$1 cm (220)
Type (n 5 477)
Tubular (257)
Tubulovillous
(220)
Atypia (n 5 479)
Mild/moderate
(453)
Severe/carcinoma in situ
or any invasion (26)

% With
adenoma
of .0.5 cm

Univariate
OR (95% CI)

Multivariate
OR (95% CI)

Discussion
11.1
31.0

1.0
1.0
3.58 (2.05–6.25) 2.71 (1.48–4.99)

12.0
17.7

1.0
1.0
1.58 (0.95–2.64) 1.30 (0.71–2.38)

10.9

1.0

19.1

1.93 (1.15–3.24) 1.39 (0.75–2.58)

14.1

1.0

23.1

1.82 (0.71–4.71) 1.31 (0.46–3.72)

1.0

1.0

To answer the question of whether having both a large
size ($1 cm) and $3 adenomas at baseline would result
in an increased risk of having multiple subsequent
adenomas above that predicted by each factor contributing separately, we examined whether there was an
interaction between the size and number of adenomas.
No significant interaction was found between these two
factors or between any of the four baseline characteristics
in their association with the number, size, or type of
follow-up adenomas.
We then asked whether any characteristics predicted
adenomas considered clinically important at follow-up,
one that was $1 cm, of villous type, or had severe or
Table 4. Relationship of Baseline Characteristics to Having a
Tubulovillous Adenoma at Follow-up
Baseline
adenoma
characteristic
Number (n 5 165)
1 or 2 (119)
$3 (46)
Size (n 5 165)
,1 cm (83)
$1 cm (82)
Type (n 5 164)
Tubular (73)
Tubulovillous
(91)
Atypia (n 5 165)
Mild/moderate
(156)
Severe/carcinoma in situ
or any invasion (9)

worse atypia. No characteristic, either singly or in
combination, was significantly associated with finding
important adenomas subsequently (Table 5).

% With a
tubulovillous
adenoma

Univariate
OR (95% CI)

Multivariate
OR (95% CI)

18.5
15.2

1.0
0.79 (0.31–2.00)

1.0
0.57 (0.20–1.63)

10.8
24.4

1.0
2.65 (1.13–6.24)

1.0
2.74 (0.93–8.03)

15.1

1.0

1.0

19.8

1.39 (0.61–3.16)

0.71 (0.24–2.14)

16.0

1.0

1.0

44.4

4.19 (1.05–16.71) 4.29 (0.83–22.17)

The analysis suggests that the number of adenomas at first colonoscopy is a significant predictor of
having recurrent adenomas found at a follow-up examination performed 3 years after clearance of the colon. This is
a finding that is similar to results from the National
Polyp Study.12 Number was an important predictive
factor of any adenoma recurrence as well as recurrence of 2
or more adenomas. Having 3 or more baseline adenomas
also increased the likelihood that adenomas found at the
follow-up examination were larger in size ($0.5 cm).
Having a tubulovillous adenoma at baseline also seems to
be a predictor of multiple recurrent adenomas, a risk
factor not reported by the National Polyp Study. Our data
show that patients with 1 or 2 tubular adenomas,
regardless of size or degree of atypia, are an identified
group with a low risk (11%) of recurrence of multiple
adenomas. In addition, 70% of such patients had no
adenomas at follow-up.
Larger size of adenomas at baseline was not found to be
a risk factor either for adenoma recurrence or for adenomas of larger size at follow-up, a finding that is contrary
to several other published reports.9,23–25 This is, in part,
explained by the difference in study design. In our
Table 5. Relationship of Baseline Characteristics to Having a
Clinically Important Adenoma at Follow-up
Baseline
adenoma
characteristic
Number (n 5 477)
1 or 2 (393)
$3 (84)
Size (n 5 477)
,1 cm (258)
$1 cm (219)
Type (n 5 475)
Tubular (256)
Tubulovillous
(219)
Atypia (n 5 477)
Mild/moderate
(451)
Severe/carcinoma in situ
or any invasion (26)

% With
important
adenoma

Univariate
OR (95% CI)

Multivariate
OR (95% CI)

3.3
6.0

1.0
1.85 (0.64–5.34)

1.0
1.13 (0.40–3.18)

4.3
3.2

1.0
0.74 (0.28–1.95)

1.0
0.49 (0.16–1.51)

3.5

1.0

1.0

4.1

1.18 (0.46–3.02)

1.34 (0.44–4.04)

3.5

1.0

1.0

7.7

2.27 (0.49–10.43) 2.50 (0.45–13.73)

NOTE. At follow-up, 65% had no adenomas and only 3.5% had an
adenoma $1 cm. A clinically important adenoma was defined as $1
cm, villous type, or with severe atypia or invasive cancer.
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analysis, the follow-up for all patients was 4 years 62
months. Other studies reported overall recurrence at
follow-up intervals of wide range. It is to be expected that
recurrent adenomas and larger lesions will be found in a
patient population followed up for a longer time.
One possible explanation of the relationship between
higher numbers of baseline adenomas and the finding of
moderate-sized adenomas at outcome is that patients
with numerous adenomas are more likely to have some
polyps missed during their first examination. Studies
addressing the miss rate of polyps at colonoscopy have
indicated that the majority of missed polyps are small,26
and one recent study reported similarly a higher miss rate
in patients with multiple polyps.22 Our analysis confirms
the clinical suspicion that a mucosa that permits the
growth of numerous tubular adenomas at baseline is the
sort that is likely to have more adenomas found at
follow-up, whereas a mucosa with few or no adenomas
does not represent a similar fertile field for adenoma
growth.
Since the publication of results from the National
Polyp Study, the standard recommendation for the follow-up of most patients with colonic adenomas has been
extended from 1 to 3 years.12 Patients with 3 or more
adenomas were identified as a subgroup with a higher
risk for adenomas with advanced pathological features at
the first follow-up examination, regardless of whether
that examination was at 1 or 3 years. Histological type as
a risk factor was not reported. A comprehensive Polyp
Guideline published in 1993 included a statement that
patients with multiple adenomas might require colonoscopy at 1 and 4 years but did not specify the definition of
‘‘multiple’’ and did not include a discussion of type as a
risk factor.27 Our analysis, in contrast, has evaluated
patient risk by analyzing the characteristics of baseline
adenomas that are known by the clinician after colonoscopic polypectomy. Knowing the number and the
histological type of baseline adenomas at first colonoscopy allows the clinician to stratify patients into low- and
high-risk groups for adenoma recurrence. Most adenomas
detected at follow-up were of minor clinical concern.
However, there is low power in our study to detect an
increased relative risk for clinically important adenomas
because of the low rate of such lesions.
From a clinical standpoint, the most useful part of
polyp characteristic analysis at baseline is probably the
identification of a low-risk group. Assuming that the
colon lining has been well seen and all polyps have been
completely removed, virtually all patients (excluding
those with a genetic syndrome), regardless of polyp
number, size, type, or degree of atypia, can probably
safely wait 3 years for a follow-up examination. Further-
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more, patients with only 1 or 2 tubular adenomas are at
particularly low risk and might be equally well served by
a longer interval before their first follow-up examination.
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